Chemical Hazard Classification

May 31, 2018

As of December 28, 2017, CalEPA has replaced the existing five(5) federal hazard categories available in CERS used for the completion of chemical inventories as part of the annual hazardous materials business submittal with twenty-four (24) new federal hazard categories adopted by the United States Environmental Protection Agency (U.S. EPA) as a result of changes to the Operational Safety and Health Administration (OSHA) Hazard Communication Standard (HCS).

Spotlight

Endocyte

Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and other serious diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company's SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently and over longer periods of time than would be possible with the untargeted drug alone. The companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.

OTHER WHITEPAPERS
news image

Protecting future generations from the manmade plastics health crisis

whitePaper | May 23, 2023

In May 2023 the European Parliament in Brussels played host to the inaugural Plastic Health Symposium. This event hosted by Sara Cerdas MEP, brought together some of the world’s top scientists, NGOs, and business leaders to discuss the plastic health crisis.

Read More
news image

Chemical Logistics Digital connections and positive reactions

whitePaper | April 8, 2020

Digitalization opens the door to a new age for the chemical industry. It paves the way for companies in the industry from material suppliers to solution and service providers. It is the driving force behind development that creates a new level of efficiency and transparency for the industry’s sensitive supply chains.

Read More
news image

Green Chemistry and Contract Synthesis – a Contradiction?

whitePaper | June 17, 2021

The topic of green chemistry is now also a challenge for contract synthesis suppliers. This is because more and more manufacturers of shampoos, detergents, paints, packaging and other consumer products are becoming increasingly concerned about the ecological footprint of their products. The trend is being fueled by consumers, who are increasingly prepared to spend more money on products that are better for the environment. But the political environment is also exerting major pressure on companies.

Read More
news image

Analysis of Hand Sanitizers to Support Label Claims

whitePaper | April 30, 2021

At the height of the first wave of the COVID-19 pandemic, consumers around the world experienced a supply shortage related to alcohol-based hand sanitizer. As new producers entered the market, and existing manufacturers sought to ramp-up production to meet the growing demand, lower grades of ethanol and isopropanol (IPA) started to appear on the market. To ensure the safety and efficacy of hand sanitizer products, it is recommended that manufacturers test their products to ensure appropriate levels of active ingredients, as well as a means of ensuring label-claim accuracy. In this application note, an efficient and simple, “dilute and shoot” method for the analysis of IPA and ethanol in hand sanitizer products is detailed. With a run-time of only 5.36 minutes per sample, this method is ideal for operations requiring fast turnaround times that won’t disrupt the production of their products.

Read More
news image

Carbon Capture and Storage, a necessary tool to fight climate change

whitePaper | June 16, 2022

Carbon Capture, Utilization and Storage (CCUS) covers all technologies dedicated to removing CO2 from flue gas, industrial gases, natural gas and the atmosphere,

Read More
news image

NEW LIFE FOR RECYCLED PLASTIC: CHARACTERIZINGPOSTCONSUMER RESIN WITH MATERIALS ANALYSIS

whitePaper | August 21, 2022

It’s impossible to think about plastics without picturing piles of soda bottles, filmy food wrappers, and other packaging floating in the ocean or washing up on the shore.

Read More

Spotlight

Endocyte

Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and other serious diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging diagnostics for personalized targeted therapies. The company's SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently and over longer periods of time than would be possible with the untargeted drug alone. The companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.

Events